V. Audard, P. Lang, and D. Sahali, Pathogénie du syndrome néphrotique à lesions glomérulaires minimes. médecine/sciences, pp.853-861, 2008.

D. Ducloux, Physiopathology and treatment of nephrotic syndrome complications
URL : https://hal.archives-ouvertes.fr/inserm-00484814

R. Bellomo and R. Atkins, Membranous Nephropathy and Thromboembolism: Is Prophylactic Anticoagulation Warranted?, Nephron, vol.63, issue.3, pp.249-54, 1993.
DOI : 10.1159/000187205

A. Rich, A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis, Bull Johns Hopkins Hosp, vol.100, issue.4, pp.173-86, 1957.

D. Agati, V. Fogo, A. Bruijn, J. Jennette, and J. , Pathologic classification of focal segmental glomerulosclerosis: a working proposal, American Journal of Kidney Diseases, vol.43, issue.2, pp.368-82, 2004.
DOI : 10.1053/j.ajkd.2003.10.024

D. Agati, V. Kaskel, F. Falk, and R. , Focal Segmental Glomerulosclerosis, New England Journal of Medicine, vol.365, issue.25, pp.2398-411, 2011.
DOI : 10.1056/NEJMra1106556

D. Sahali, V. Audard, P. Rémy, and P. Lang, Syndromes n??phrotiques idiopathiques??: physiopathologie et prise en charge th??rapeutique sp??cifique chez l???adulte, N??phrologie & Th??rapeutique, vol.8, issue.3, pp.180-92, 2012.
DOI : 10.1016/j.nephro.2011.11.010

Y. Ahn, E. Park, H. Kang, S. Kim, H. Cho et al., Genotype???phenotype analysis of pediatric patients with WT1 glomerulopathy, Pediatric Nephrology, vol.143, issue.Suppl 3, 2016.
DOI : 10.1007/s00467-016-3395-4

P. Ronco and H. Debiec, Molecular pathomechanisms of membranous nephropathy: from

P. Ronco and H. Debiec, Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients, Molecular Immunology, vol.68, issue.1, pp.57-62
DOI : 10.1016/j.molimm.2015.07.003

S. Satchell and F. Braet, Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier, AJP: Renal Physiology, vol.296, issue.5, pp.947-56, 2009.
DOI : 10.1152/ajprenal.90601.2008

K. Tryggvason, J. Patrakka, and J. Wartiovaara, Hereditary Proteinuria Syndromes and Mechanisms of Proteinuria, New England Journal of Medicine, vol.354, issue.13, pp.1387-401, 2006.
DOI : 10.1056/NEJMra052131

H. Pavenstädt, W. Kriz, and M. Kretzler, Cell Biology of the Glomerular Podocyte, Physiological Reviews, vol.83, issue.1, pp.253-307, 2003.
DOI : 10.1152/physrev.00020.2002

W. Deen, What determines glomerular capillary permeability?, Journal of Clinical Investigation, vol.114, issue.10, 2004.
DOI : 10.1172/JCI23577

R. Verma, B. Wharram, I. Kovari, R. Kunkel, D. Nihalani et al., Fyn Binds to and Phosphorylates the Kidney Slit Diaphragm Component Nephrin, Journal of Biological Chemistry, vol.278, issue.23, pp.20716-20739, 2003.
DOI : 10.1074/jbc.M301689200

H. Li, Src-Family Kinase Fyn Phosphorylates the Cytoplasmic Domain of Nephrin and Modulates Its Interaction with Podocin, Journal of the American Society of Nephrology, vol.15, issue.12, pp.3006-3021, 2004.
DOI : 10.1097/01.ASN.0000146689.88078.80

I. Quack, L. Rump, P. Gerke, I. Walther, T. Vinke et al., beta-Arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity, Proceedings of the National Academy of Sciences, vol.103, issue.38, pp.14110-14115, 2006.
DOI : 10.1073/pnas.0602587103

T. Huber, B. Hartleben, J. Kim, M. Schmidts, B. Schermer et al., Nephrin and CD2AP Associate with Phosphoinositide 3-OH Kinase and Stimulate AKT-Dependent Signaling, Molecular and Cellular Biology, vol.23, issue.14, pp.4917-4945, 2003.
DOI : 10.1128/MCB.23.14.4917-4928.2003

N. Jones, I. Blasutig, V. Eremina, J. Ruston, F. Bladt et al., Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes, Nature, vol.401, issue.7085, pp.818-841, 2006.
DOI : 10.1038/nature04662

R. Verma, Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization, Journal of Clinical Investigation, vol.116, issue.5, pp.1346-59, 2006.
DOI : 10.1172/JCI27414

M. Chen, H. She, E. Davis, C. Spicer, L. Kim et al., Identification of Nck Family Genes, Chromosomal Localization, Expression, and Signaling Specificity, Journal of Biological Chemistry, vol.273, issue.39, pp.25171-25179, 1998.
DOI : 10.1074/jbc.273.39.25171

V. Eremina, H. Baelde, and S. Quaggin, Role of the VEGF-A Signaling Pathway in the Glomerulus: Evidence for Crosstalk between Components of the Glomerular Filtration Barrier, Nephron Physiology, vol.106, issue.2
DOI : 10.1159/000101798

H. Izzedine, M. Mangier, V. Ory, S. Zhang, K. Sendeyo et al., Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy, Kidney International, vol.85, issue.2, pp.457-70, 2014.
DOI : 10.1038/ki.2013.344

URL : https://hal.archives-ouvertes.fr/inserm-00958760

A. Ali, E. Wilson, J. Moorhead, P. Amlot, A. Abdulla et al., Minimalchange glomerular nephritis. Normal kidneys in an abnormal environment? Transplantation, pp.849-52, 1994.

R. Rea, C. Smith, K. Sandhu, J. Kwan, and C. Tomson, Successful transplant of a kidney with focal segmental glomerulosclerosis, Nephrology Dialysis Transplantation, vol.16, issue.2, pp.416-423, 2001.
DOI : 10.1093/ndt/16.2.416

L. Gallon, J. Leventhal, A. Skaro, Y. Kanwar, and A. Alvarado, Resolution of Recurrent Focal Segmental Glomerulosclerosis after Retransplantation, New England Journal of Medicine, vol.366, issue.17, pp.1648-1657, 2012.
DOI : 10.1056/NEJMc1202500

D. Ginsburg and P. Dau, Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis, Clin Nephrol, vol.48, issue.5, pp.282-289, 1997.

S. Feld, P. Figueroa, V. Savin, C. Nast, R. Sharma et al., Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys, American Journal of Kidney Diseases, vol.32, issue.2, pp.230-237, 1998.
DOI : 10.1053/ajkd.1998.v32.pm9708606

F. Vincenti and G. Ghiggeri, New Insights into the Pathogenesis and the Therapy of Recurrent Focal Glomerulosclerosis, American Journal of Transplantation, vol.1, issue.6, pp.1179-85, 2005.
DOI : 10.1034/j.1600-6143.2002.21005.x

R. Davenport, Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: Re-analysis of published case-reports and case-series, Journal of Clinical Apheresis, vol.46, issue.4, pp.175-183, 2001.
DOI : 10.1002/jca.10007

M. Kemper, G. Wolf, and D. Müller-wiefel, Transmission of Glomerular Permeability Factor from a Mother to Her Child, New England Journal of Medicine, vol.344, issue.5, pp.386-393, 2001.
DOI : 10.1056/NEJM200102013440517

S. Zimmerman, Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation, Clin Nephrol, vol.22, issue.1, pp.32-40, 1984.

M. Sharma, R. Sharma, S. Reddy, E. Mccarthy, and V. Savin, Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation, Feb, vol.1573, issue.3, pp.366-72, 2002.

G. Lagrue, S. Xheneumont, A. Branellec, G. Hirbec, and B. Weil, A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome

J. Dantal, E. Bigot, W. Bogers, A. Testa, F. Kriaa et al., Effect of Plasma Protein Adsorption on Protein Excretion in Kidney-Transplant Recipients with Recurrent Nephrotic Syndrome, New England Journal of Medicine, vol.330, issue.1, pp.7-14, 1994.
DOI : 10.1056/NEJM199401063300102

V. Savin, E. Mccarthy, and M. Sharma, Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis, Kidney Research and Clinical Practice, vol.31, issue.4, pp.205-218, 2012.
DOI : 10.1016/j.krcp.2012.10.002

H. Kimata, M. Fujimoto, and K. Furusho, Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome, European Journal of Immunology, vol.343, issue.6, 1995.
DOI : 10.1002/eji.1830250604

K. Lai, C. Wei, L. Tan, P. Tan, G. Chiang et al., Overexpression of Interleukin-13 Induces Minimal-Change-Like Nephropathy in Rats, Journal of the American Society of Nephrology, vol.18, issue.5, 2007.
DOI : 10.1681/ASN.2006070710

G. Cara-fuentes, C. Wei, A. Segarra, T. Ishimoto, C. Rivard et al., CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance, Pediatric Nephrology, vol.27, issue.8, pp.1363-71, 2014.
DOI : 10.1007/s00467-013-2679-1

R. Lennon, A. Singh, G. Welsh, R. Coward, S. Satchell et al., Hemopexin Induces Nephrin-Dependent Reorganization of the Actin Cytoskeleton in Podocytes, Journal of the American Society of Nephrology, vol.19, issue.11, pp.2140-2149, 2008.
DOI : 10.1681/ASN.2007080940

E. Königshausen and L. Sellin, Circulating Permeability Factors in Primary Focal

C. Wei, S. Hindi, J. Li, A. Fornoni, N. Goes et al., Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis, Nature Medicine, vol.119, issue.8, pp.952-60, 2011.
DOI : 10.1159/000093259

C. Wei, H. Trachtman, J. Li, C. Dong, A. Friedman et al., Circulating suPAR in Two Cohorts of Primary FSGS, Journal of the American Society of Nephrology, vol.23, issue.12, pp.2051-2060, 2012.
DOI : 10.1681/ASN.2012030302

D. Bock, C. Wang, and Y. , Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer, Medicinal Research Reviews, vol.20, issue.1, pp.13-39, 2004.
DOI : 10.1002/med.10054

E. Mccarthy, M. Sharma, and V. Savin, Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis, Clinical Journal of the American Society of Nephrology, vol.5, issue.11, 2010.
DOI : 10.2215/CJN.03800609

M. Delville, T. Sigdel, C. Wei, J. Li, S. Hsieh et al., A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation, Science Translational Medicine, vol.6, issue.256
DOI : 10.1126/scitranslmed.3008538

R. Shalhoub, PATHOGENESIS OF LIPOID NEPHROSIS: A DISORDER OF T-CELL FUNCTION, The Lancet, vol.304, issue.7880
DOI : 10.1016/S0140-6736(74)91880-7

P. Grimbert, V. Audard, R. P. Lang, P. Sahali, and D. , Recent approaches to the pathogenesis of minimal-change nephrotic syndrome, Nephrology Dialysis Transplantation, vol.18, issue.2, pp.245-253, 2003.
DOI : 10.1093/ndt/18.2.245

R. Bertelli, A. Bonanni, D. Donato, A. Cioni, M. Ravani et al., Regulatory T cells and minimal change nephropathy: in the midst of a complex network, Clinical & Experimental Immunology, vol.22, issue.2, pp.166-74, 2016.
DOI : 10.1111/cei.12675

D. Sahali, A. Pawlak, A. Valanciuté, P. Grimbert, P. Lang et al., A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening, J Am Soc Nephrol, vol.13, issue.5, pp.1238-1285, 2002.

C. Truncation-of, Tc-mip), a New Proximal Signaling Protein, Induces c-maf Th2 Transcription Factor and Cytoskeleton Reorganization, J Exp Med, vol.198, issue.5, pp.797-807, 2003.

P. Grimbert, A. Valanciute, V. Audard, P. Lang, G. Guellaën et al., The Filamin-A is a partner of Tc-mip, a new adapter protein involved in c-maf-dependent Th2 signaling pathway, Molecular Immunology, vol.40, issue.17, pp.1257-61, 2004.
DOI : 10.1016/j.molimm.2003.11.035

M. Kamal, A. Valanciute, K. Dahan, V. Ory, A. Pawlak et al., C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity, Molecular Immunology, vol.46, issue.5, 2009.
DOI : 10.1016/j.molimm.2008.09.034

P. Ronco, Paraneoplastic glomerulopathies: New insights into an old entity, Kidney International, vol.56, issue.1, pp.355-77, 1999.
DOI : 10.1046/j.1523-1755.1999.00548.x

P. Mathieson, Immune dysregulation in minimal change nephropathy, Nephrology Dialysis Transplantation, vol.18, issue.90006, pp.26-29, 2003.
DOI : 10.1093/ndt/gfg1066

M. Afanetti, Rituximab treatment for severe steroid-or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases, Pediatr Nephrol Berl Ger, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00453355

U. Lenkkeri, M. Männikkö, J. Lamerdin, P. Mccready, and H. Putaala, Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis, Sci Transl Med, vol.3, issue.85, 2011.

N. Boute, O. Gribouval, S. Roselli, F. Benessy, H. Lee et al., NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome, Nat Genet, vol.24, issue.4, pp.349-54, 2000.

H. Mohey, L. Thibaudin, B. Laurent, and F. Berthoux, The podocin mutation R229Q and early recurrence (within the first year) of glomerular disease after renal transplantation, Ann Transplant, vol.18, pp.436-478, 2013.

J. Kaplan, S. Kim, K. North, H. Rennke, L. Correia et al., Mutations in ACTN4, encoding ??-actinin-4, cause familial focal segmental glomerulosclerosis, Nature Genetics, vol.6, issue.3, pp.251-257, 2000.
DOI : 10.1038/7675

J. Reiser, K. Polu, C. Möller, P. Kenlan, M. Altintas et al., TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function, Nature Genetics, vol.11, issue.7, pp.739-783, 2005.
DOI : 10.1006/jmbi.2000.4042

M. Winn, P. Conlon, K. Lynn, M. Farrington, T. Creazzo et al., A Mutation in the TRPC6 Cation Channel Causes Familial Focal Segmental Glomerulosclerosis, Science, vol.308, issue.5729
DOI : 10.1126/science.1106215

M. Löwik, P. Groenen, I. Pronk, M. Lilien, R. Goldschmeding et al., Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation, Kidney International, vol.72, issue.10
DOI : 10.1038/sj.ki.5002469

E. Denamur, N. Bocquet, B. Mougenot, D. Silva, F. Martinat et al., Motherto-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases, J

O. Boyer, S. Woerner, F. Yang, E. Oakeley, B. Linghu et al., LMX1B Mutations Cause Hereditary FSGS without Extrarenal Involvement, Journal of the American Society of Nephrology, vol.24, issue.8, 2013.
DOI : 10.1681/ASN.2013020171

V. Audard, S. Zhang, C. Copie-bergman, C. Rucker-martin, V. Ory et al., Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip
URL : https://hal.archives-ouvertes.fr/inserm-00485558

L. Beck, A. Bomback, M. Choi, L. Holzman, C. Langford et al., KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis Kidney Disease : Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis, Am J Kidney Dis. Kidney Inter, vol.622, issue.83, pp.403-41139, 2012.

D. Black, G. Rose, and D. Brewer, Controlled Trial of Prednisone in Adult Patients with the Nephrotic Syndrome, BMJ, vol.3, issue.5720, pp.421-427, 1970.
DOI : 10.1136/bmj.3.5720.421

S. Mak, C. Short, and N. Mallick, Long-term outcome of adult-onset minimal-change nephropathy, Nephrology Dialysis Transplantation, vol.11, issue.11, pp.2192-201, 1996.
DOI : 10.1093/oxfordjournals.ndt.a027136

A. Meyrier, Treatment of idiopathic nephrosis by immunophillin modulation, Nephrology Dialysis Transplantation, vol.18, issue.90006, pp.79-86, 2003.
DOI : 10.1093/ndt/gfg1067

A. Eguchi, T. Takei, T. Yoshida, K. Tsuchiya, and K. Nitta, Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome, Nephrology Dialysis Transplantation, vol.25, issue.1, pp.124-133, 2010.
DOI : 10.1093/ndt/gfp422

H. Lee, H. Kim, C. Kang, S. Kim, and M. Kim, The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea, Clin Nephrol, vol.43, issue.6, pp.375-81, 1995.

T. Ittel, W. Clasen, M. Fuhs, J. Kindler, M. Mihatsch et al., Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis, Clin Nephrol, vol.44, issue.3, pp.156-62, 1995.

D. Cattran, G. Appel, L. Hebert, L. Hunsicker, M. Pohl et al., A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis, Kidney International, vol.56, issue.6, 1999.
DOI : 10.1046/j.1523-1755.1999.00778.x

P. Heering, N. Braun, R. Müllejans, K. Ivens, I. Zäuner et al., Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis, American Journal of Kidney Diseases, vol.43, issue.1, pp.10-18, 2004.
DOI : 10.1053/j.ajkd.2003.09.027

C. Day, P. Cockwell, G. Lipkin, C. Savage, A. Howie et al., Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome, Nephrology Dialysis Transplantation, vol.17, issue.11, pp.2011-2014, 2002.
DOI : 10.1093/ndt/17.11.2011

T. Westhoff, S. Schmidt, W. Zidek, J. Beige, and M. Van-der-giet, Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome, Clinical Nephrology, vol.65, issue.06, pp.393-400, 2006.
DOI : 10.5414/CNP65393

A. Segarra, J. Vila, L. Pou, J. Majó, A. Arbós et al., Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up, Nephrology Dialysis Transplantation, vol.17, issue.4, pp.655-62, 2002.
DOI : 10.1093/ndt/17.4.655

X. Li, H. Li, H. Ye, Q. Li, X. He et al., Tacrolimus Therapy in Adults With Steroid- and Cyclophosphamide-Resistant Nephrotic Syndrome and Normal or Mildly Reduced GFR, American Journal of Kidney Diseases, vol.54, issue.1, pp.51-59, 2009.
DOI : 10.1053/j.ajkd.2009.02.018

J. Guitard, A. Hebral, F. Fakhouri, D. Joly, E. Daugas et al., Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance, Nephrology Dialysis Transplantation, vol.29, issue.11, pp.2084-91, 2014.
DOI : 10.1093/ndt/gfu209

A. Sinha and A. Bagga, Rituximab therapy in nephrotic syndrome: implications for patients' management, Nature Reviews Nephrology, vol.25, issue.3, pp.154-69
DOI : 10.1038/nrneph.2012.289

H. Munyentwali, K. Bouachi, V. Audard, R. P. Lang, P. Mojaat et al., Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease, Kidney International, vol.83, issue.3
DOI : 10.1038/ki.2012.444

URL : https://hal.archives-ouvertes.fr/inserm-00919110

Y. Iwabuchi, T. Takei, T. Moriyama, M. Itabashi, and K. Nitta, Long-Term Prognosis of Adult Patients with Steroid-Dependent Minimal Change Nephrotic Syndrome Following Rituximab Treatment, Medicine, vol.93, issue.29, p.300, 2014.
DOI : 10.1097/MD.0000000000000300

M. Dekkers, J. Groothoff, R. Zietse, and M. Betjes, A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood, BMC Research Notes, vol.24, issue.1, 2015.
DOI : 10.1186/s13104-015-1255-0

A. Beer, G. Mayer, and A. Kronbichler, Treatment Strategies of Adult Primary Focal 94

T. Kobayashi, Y. Ando, T. Umino, Y. Miyata, S. Muto et al., Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy, Clinical Nephrology, vol.65, issue.06, pp.423-429, 2006.
DOI : 10.5414/CNP65423

K. Yokoyama, S. Sakai, T. Sigematsu, F. Takemoto, S. Hara et al., LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy, Clin Nephrol, vol.50, issue.1, pp.1-7, 1998.

E. Muso, M. Mune, Y. Fujii, E. Imai, N. Ueda et al., Significantly Rapid Relief from Steroid-Resistant Nephrotic Syndrome by LDL Apheresis Compared with Steroid Monotherapy, Nephron, vol.89, issue.4, pp.408-423, 2001.
DOI : 10.1159/000046112

J. Zhou, Y. Zhang, G. Liu, J. Li, R. Xu et al., Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease, Clinical Nephrology, vol.80, issue.08, pp.121-130, 2013.
DOI : 10.5414/CN107723

J. Hogan, A. Bomback, K. Mehta, P. Canetta, M. Rao et al., Treatment of Idiopathic FSGS with Adrenocorticotropic Hormone Gel, Clinical Journal of the American Society of Nephrology, vol.8, issue.12, pp.2072-81, 2013.
DOI : 10.2215/CJN.02840313

A. Peyser, N. Machardy, F. Tarapore, J. Machardy, L. Powell et al., Followup of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group, BMC Nephrol, vol.11, issue.2, 2010.

H. Trachtman, S. Vento, E. Herreshoff, M. Radeva, J. Gassman et al., Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group, BMC Nephrology, vol.66, issue.8 Suppl, 2015.
DOI : 10.1016/j.jclinepi.2013.04.006

K. Sgambat, M. Banks, and A. Moudgil, Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome, Pediatric Nephrology, vol.5, issue.11, 2013.
DOI : 10.1007/s00467-013-2539-z

L. Jiang, I. Dasgupta, J. Hurcombe, H. Colyer, P. Mathieson et al., Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte, Clinical Science, vol.126, issue.12, pp.883-93, 1979.
DOI : 10.1152/ajprenal.00161.2010

E. Yanik, C. Clarke, J. Snyder, R. Pfeiffer, and E. Engels, Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals, Journal of the American Society of Nephrology, vol.27, issue.5
DOI : 10.1681/ASN.2015040373

W. Lim and S. Chadban, Cancer in ESRD: Clear on the Epidemiology, Hazy on the Mechanisms, Journal of the American Society of Nephrology, vol.27, issue.5, pp.1272-1277, 2016.
DOI : 10.1681/ASN.2015091021

H. Lee, K. Yoo, Y. Oh, D. Kim, K. Oh et al., Predictors of Relapse in Adult-Onset Nephrotic Minimal Change Disease, Medicine, vol.95, issue.12, p.3179, 2016.
DOI : 10.1097/MD.0000000000003179

M. Artero, C. Biava, W. Amend, S. Tomlanovich, and F. Vincenti, Recurrent focal glomerulosclerosis: Natural history and response to therapy, The American Journal of Medicine, vol.92, issue.4, pp.375-83, 1992.
DOI : 10.1016/0002-9343(92)90267-F

E. Kim, J. Striegel, Y. Kim, A. Matas, J. Najarian et al., Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection, Kidney International, vol.45, issue.5, pp.1440-1445, 1994.
DOI : 10.1038/ki.1994.188

K. Abbott, E. Sawyers, J. Oliver, C. Ko, A. Kirk et al., Graft Loss Due to Recurrent Focal Segmental Glomerulosclerosis in Renal Transplant Recipients in the United States, American Journal of Kidney Diseases, vol.37, issue.2, pp.366-73, 2001.
DOI : 10.1053/ajkd.2001.21311

D. Cibrik, B. Kaplan, D. Campbell, H. Meier-kriesche, and H. Kriesche, Renal Allograft Survival in Transplant Recipients with Focal Segmental Glomerulosclerosis, American Journal of Transplantation, vol.71, issue.1, pp.64-71, 2003.
DOI : 10.1046/j.1523-1755.2001.00494.x

S. Chadban, Glomerulonephritis recurrence in the renal graft, J Am Soc Nephrol, 2001.

G. Canaud, D. Dion, J. Zuber, M. Gubler, R. Sberro et al., Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS), Nephrology Dialysis Transplantation, vol.25, issue.4, pp.1321-1329, 2010.
DOI : 10.1093/ndt/gfp500

T. Bosch and T. Wendler, Extracorporeal plasma treatment in primary and recurrent focal 96

J. Deegens, M. Andresdottir, S. Croockewit, and J. Wetzels, Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation, Transplant International, vol.75, issue.3, pp.151-158, 2004.
DOI : 10.1093/ndt/15.1.78

G. Canaud, F. Martinez, L. Noël, M. Mamzer, P. Niaudet et al., Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients, Transplantation Reviews, vol.24, issue.3, pp.121-129, 2010.
DOI : 10.1016/j.trre.2010.04.001

M. Marasà and J. Kopp, Monoclonal antibodies for podocytopathies: rationale and clinical responses, Nature Reviews Nephrology, vol.216, issue.6, pp.337-385, 2009.
DOI : 10.1038/nrneph.2009.70

F. Nolasco, J. Cameron, E. Heywood, J. Hicks, C. Ogg et al., Adult???onset minimal change nephrotic syndrome: A long???term follow???up, Kidney International, vol.29, issue.6, 1986.
DOI : 10.1038/ki.1986.130

R. Nair, A. Date, M. Kirubakaran, and J. Shastry, Minimal-Change Nephrotic Syndrome in Adults Treated with Alternate-Day Steroids, Nephron, vol.47, issue.3, pp.209-219, 1987.
DOI : 10.1159/000184494

S. Korbet, M. Schwartz, and E. Lewis, Minimal-Change Glomerulopathy of Adulthood, American Journal of Nephrology, vol.8, issue.4
DOI : 10.1159/000167603

S. Fujimoto, Y. Yamamoto, S. Hisanaga, S. Morita, T. Eto et al., Minimal Change Nephrotic Syndrome in Adults: Response to Corticosteroid Therapy and Frequency of Relapse, American Journal of Kidney Diseases, vol.17, issue.6
DOI : 10.1016/S0272-6386(12)80353-2

J. Huang, S. Hsu, F. Chen, J. Sung, C. Tseng et al., Adult-Onset Minimal Change Disease among Taiwanese, American Journal of Nephrology, vol.21, issue.1, pp.28-34, 2001.
DOI : 10.1159/000046215

M. Nakayama, R. Katafuchi, T. Yanase, K. Ikeda, H. Tanaka et al., Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome, American Journal of Kidney Diseases, vol.39, issue.3
DOI : 10.1053/ajkd.2002.31400

K. Tse, M. Lam, P. Yip, F. Li, B. Choy et al., Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses, Nephrology Dialysis Transplantation, vol.18, issue.7
DOI : 10.1093/ndt/gfg134

M. Shinzawa, R. Yamamoto, Y. Nagasawa, S. Oseto, D. Mori et al., Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort study, Clinical and Experimental Nephrology, vol.50, issue.11, 2013.
DOI : 10.1007/s10157-013-0793-9

G. Fernandez-juarez, J. Villacorta, G. Ruiz-roso, N. Panizo, I. Martinez-marín et al., Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis, Clinical Kidney Journal, vol.9, issue.3, pp.381-387
DOI : 10.1093/ckj/sfw028

S. Korbet, M. Schwartz, and E. Lewis, The prognosis of focal segmental glomerular sclerosis of adulthood. Medicine (Baltimore), pp.304-315, 1986.

G. Banfi, M. Moriggi, E. Sabadini, G. Fellin, D. Amico et al., The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults

S. Korbet, M. Schwartz, and E. Lewis, Primary Focal Segmental Glomerulosclerosis: Clinical Course and Response to Therapy, American Journal of Kidney Diseases, vol.23, issue.6, pp.773-83, 1994.
DOI : 10.1016/S0272-6386(12)80128-4

J. Rydel, S. Korbet, R. Borok, and M. Schwartz, Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment, American Journal of Kidney Diseases, vol.25, issue.4, pp.534-576, 1995.
DOI : 10.1016/0272-6386(95)90120-5

E. Alexopoulos, M. Stangou, A. Papagianni, A. Pantzaki, and M. Papadimitriou, Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis, Nephrology Dialysis Transplantation, vol.15, issue.9, pp.1348-56, 2000.
DOI : 10.1093/ndt/15.9.1348

S. Troyanov, C. Wall, J. Miller, J. Scholey, and D. Cattran, Focal and Segmental Glomerulosclerosis: Definition and Relevance of a Partial Remission, Journal of the American Society of Nephrology, vol.16, issue.4, pp.1061-1069, 2005.
DOI : 10.1681/ASN.2004070593

J. Vlasi?-matas, G. Durdov, M. Capkun, V. Galesi?, and K. , Prognostic value of clinical, laboratory, and morphological factors in patients with primary focal segmental glomerulosclerosis -distribution of pathological variants in the Croatian population, Med Sci Monit, vol.15, issue.10, pp.121-129, 2009.

N. Jafry, E. Ahmed, M. Mubarak, J. Kazi, and F. Akhter, Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults, Nephrology Dialysis Transplantation, vol.27, issue.3, pp.1101-1107, 2012.
DOI : 10.1093/ndt/gfr430

Y. Kwon, S. Han, J. Kie, S. An, Y. Kim et al., Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients, BMC Nephrology, vol.26, issue.7
DOI : 10.1093/ndt/gfq668

A. Greenwood, R. Gunnarsson, B. Neuen, K. Oliver, S. Green et al., Clinical presentation, treatment and outcome of focal segmental glomerulosclerosis in Far North Queensland Australian adults, Nephrology, 2016.
DOI : 10.1111/nep.12816

Y. Pei, D. Cattran, T. Delmore, A. Katz, A. Lang et al., Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis, The American Journal of Medicine, vol.82, issue.5, pp.938-982, 1987.
DOI : 10.1016/0002-9343(87)90155-0

S. Korbet, Clinical picture and outcome of primary focal segmental glomerulosclerosis, Nephrology Dialysis Transplantation, vol.14, issue.90003, pp.68-73, 1999.
DOI : 10.1093/ndt/14.suppl_3.68

S. Klahr, A. Levey, G. Beck, A. Caggiula, L. Hunsicker et al., The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease, New England Journal of Medicine, vol.330, issue.13, pp.877-84, 1994.
DOI : 10.1056/NEJM199403313301301

P. Niaudet, Genetic forms of nephrotic syndrome, Pediatric Nephrology, vol.13, issue.12, 2004.
DOI : 10.1007/s00467-004-1676-9

A. Sumnu, M. Gursu, and S. Ozturk, Primary glomerular diseases in the elderly, World Journal of Nephrology, vol.4, issue.2, pp.263-70, 2015.
DOI : 10.5527/wjn.v4.i2.263

P. Passerini, G. Como, E. Viganò, P. Melis, C. Pozzi et al., Idiopathic membranous nephropathy in the elderly, Nephrol Dial Transplant, vol.8, issue.12, pp.1321-1326, 1993.

R. Zent, R. Nagai, and D. Cattran, Idiopathic membranous nephropathy in the elderly: A comparative study, American Journal of Kidney Diseases, vol.29, issue.2, pp.200-206, 1997.
DOI : 10.1016/S0272-6386(97)90030-5

C. Ponticelli, P. Zucchelli, P. Passerini, L. Cagnoli, B. Cesana et al., A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy, New England Journal of Medicine, vol.320, issue.1, pp.8-13, 1989.
DOI : 10.1056/NEJM198901053200102

T. Ito, K. Mochizuki, T. Oka, K. Hanada, and K. Tanabe, Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine, International Urology and Nephrology, vol.46, issue.5, pp.131-136
DOI : 10.1007/s11255-014-0850-7

J. Zwaginga, H. Koomans, J. Sixma, and T. Rabelink, Thrombus formation and plateletvessel wall interaction in the nephrotic syndrome under flow conditions, J Clin Invest, 1994.

R. Kauffmann, J. Veltkamp, V. Tilburg, N. Van-es, and L. , Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome, The American Journal of Medicine, vol.65, issue.4, pp.607-620, 1978.
DOI : 10.1016/0002-9343(78)90848-3

A. Robert, M. Olmer, J. Sampol, J. Gugliotta, and P. Casanova, Clinical correlation between hypercoagulability and thrombo-embolic phenomena, Kidney International, vol.31, issue.3, pp.830-835, 1987.
DOI : 10.1038/ki.1987.73

A. Kanfer, Coagulation Factors in Nephrotic Syndrome, American Journal of Nephrology, vol.10, issue.1, pp.63-71, 1990.
DOI : 10.1159/000168196

C. Magee, Kidney Disease and Death From Cancer, American Journal of Kidney Diseases, vol.63, issue.1, pp.7-9, 2014.
DOI : 10.1053/j.ajkd.2013.10.003

E. Cohen, J. Krzesinski, V. Launay-vacher, and B. Sprangers, Onco-Nephrology: Core Curriculum 2015, American Journal of Kidney Diseases, vol.66, issue.5, pp.869-83, 2015.
DOI : 10.1053/j.ajkd.2015.04.042

M. Chun, S. Korbet, M. Schwartz, and E. Lewis, Focal Segmental Glomerulosclerosis in Nephrotic Adults: Presentation, Prognosis, and Response to Therapy of the Histologic Variants, Journal of the American Society of Nephrology, vol.15, issue.8, pp.2169-77, 2004.
DOI : 10.1097/01.ASN.0000135051.62500.97

L. Laurin, A. Gasim, C. Poulton, S. Hogan, J. Jennette et al., Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS, Clinical Journal of the American Society of Nephrology, vol.11, issue.3, pp.386-94, 2016.
DOI : 10.2215/CJN.07110615

D. Almaguer, F. Lavalle-gonzalez, and H. Tamez-perez, Hyperglycemia related to highdose glucocorticoid use in noncritically ill patients, Diabetol Metab Syndr, vol.5, p.18, 2013.

H. Tamez-pérez, D. Quintanilla-flores, R. Rodríguez-gutiérrez, J. González-gonzález, and A. Tamez-peña, Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review, World Journal of Diabetes, vol.6, issue.8, pp.1073-81, 2015.
DOI : 10.4239/wjd.v6.i8.1073

D. Goldmannova, D. Karasek, O. Krystynik, and J. Zadrazil, New-onset diabetes mellitus after renal transplantation, Biomedical Papers, vol.160, issue.2, 2016.
DOI : 10.5507/bp.2016.005

M. Roland, P. Gatault, A. Najjar, C. Doute, C. Barbet et al., Early Pulse Pressure and Low-Grade Proteinuria as Independent Long-Term Risk Factors for New-Onset Diabetes Mellitus After Kidney Transplantation, American Journal of Transplantation, vol.72, issue.8, pp.1719-1747, 2008.
DOI : 10.1111/j.1600-6143.2008.02308.x

M. Hecking, M. Haidinger, D. Döller, J. Werzowa, A. Tura et al., Early Basal Insulin Therapy Decreases New-Onset Diabetes after Renal Transplantation, Journal of the American Society of Nephrology, vol.23, issue.4, pp.739-788
DOI : 10.1681/ASN.2011080835

A. Stuck, C. Minder, and F. Frey, Risk of Infectious Complications in Patients Taking Glucocorticosteroids, Clinical Infectious Diseases, vol.11, issue.6, pp.954-63, 1989.
DOI : 10.1093/clinids/11.6.954

E. Garin, W. Mu, J. Arthur, C. Rivard, C. Araya et al., Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis, Kidney International, vol.78, issue.3, pp.296-302, 2010.
DOI : 10.1038/ki.2010.143